Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
CAPS Rating:
A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.
RSS Headlines
Fool UK
Recs
M* 5 Star Pick
No any more...